Harmony Biosciences (HRMY)
(Delayed Data from NSDQ)
$37.76 USD
+0.48 (1.29%)
Updated Sep 12, 2024 04:00 PM ET
After-Market: $37.75 -0.01 (-0.03%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth C Momentum B VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 33% (80 out of 251)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.89 | 1.37 | 9.99 |
Current Quarter Estimate | 0.60 | 2.89 | 61.00 |
Year Ago Quarter Estimate | 0.63 | -4.83 | 54.84 |
Next Quarter Estimate | 0.56 | 3.94 | 63.00 |
Next Year Estimate | 3.49 | 25.11 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 2.82 | 17.50 | 15.67 |
Next Year | 59.36 | 9.70 | 11.34 |
Last 5 Years | NA | 0.90 | 8.10 |
Next 5 Years | 22.80 | 21.80 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 19.12 | -7.39 |
Price/Book (MRQ) | 3.93 | 1.97 |
Price/Cash Flow (MRFY) | 14.29 | 16.43 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 17.53% | -152.35% |
Return on Equity (TTM) | 22.97% | -60.91% |
Debt to Equity (MRQ) | 0.32 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.